Published in Br J Psychiatry on September 01, 1985
The human serum metabolome. PLoS One (2011) 5.55
Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide. Psychopharmacology (Berl) (2013) 1.95
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr Res (2008) 1.14
Dietary taurine intake, nutrients intake, dietary habits and life stress by depression in Korean female college students: a case-control study. J Biomed Sci (2010) 1.06
D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. Eur Arch Psychiatry Clin Neurosci (2012) 0.93
Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology. Neuropsychopharmacology (2013) 0.92
Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network. FEBS Open Bio (2014) 0.88
Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis. Behav Brain Funct (2014) 0.79
13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients. Transl Psychiatry (2012) 0.79
Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophrenia. J Neurol Neurosurg Psychiatry (1987) 0.78
Peripheral amino Acid levels in schizophrenia and antipsychotic treatment. Psychiatry Investig (2008) 0.78
Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia. Curr Pharm Biotechnol (2012) 0.77
Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with Controls. Comput Struct Biotechnol J (2016) 0.76
Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? PLoS One (2014) 0.76
Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia. Front Public Health (2016) 0.75
Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis. Front Neurosci (2016) 0.75
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry (1992) 2.84
A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl (1978) 2.50
Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty acids, and amino acids. J Clin Invest (1974) 2.40
Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J Clin Invest (1976) 2.27
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry (1995) 1.80
Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg (1985) 1.75
Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (1986) 1.70
Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest (1972) 1.63
Debrisoquine hydroxylation polymorphism and personality. Lancet (1989) 1.62
Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab (1999) 1.56
A gas chromatographic method for the determination of individual free fatty acids in plasma. Clin Chim Acta (1966) 1.47
Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. J Clin Invest (1975) 1.46
D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Arch Gen Psychiatry (1990) 1.42
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry (1993) 1.41
Retrospective diagnosis of 3-hydroxydicarboxylic aciduria by analysis of filter paper blood samples. J Inherit Metab Dis (1990) 1.39
Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry (1988) 1.38
Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology (1994) 1.38
Perinatal origin of adult self-destructive behavior. Acta Psychiatr Scand (1987) 1.29
Human forearm muscle metabolism during exercise. II. Uptake, release and oxidation of individual FFA and glycerol. Scand J Clin Lab Invest (1968) 1.28
Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res (1997) 1.26
A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet (2003) 1.24
Swedish universities Scales of Personality (SSP): construction, internal consistency and normative data. Acta Psychiatr Scand (2000) 1.24
Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed) (1984) 1.23
Substrate utilization by the inactive leg during one-leg or arm exercise. J Appl Physiol (1975) 1.23
Expectation and experiences of childbirth in primiparae with caesarean section. BJOG (2008) 1.20
Pyroglutamic aciduria (5-oxoprolinuria), an inborn error in glutathione metabolism. Pediatr Res (1974) 1.19
D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res (1998) 1.17
In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet (1988) 1.15
Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand (1987) 1.13
Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. J Clin Invest (1977) 1.13
Does Swedish amateur boxing lead to chronic brain damage? 1. A retrospective medical, neurological and personality trait study. Acta Neurol Scand (1990) 1.13
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol (1987) 1.13
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain (1997) 1.12
Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J Clin Invest (1984) 1.12
Splenic transplantation in a case of Gaucher's disease. Lancet (1971) 1.12
Photic and neural control of the 24-hour norepinephrine rhythm in the rat pineal gland. J Pharmacol Exp Ther (1967) 1.11
Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (1997) 1.09
Physical exercise and fuel homeostasis in diabetes mellitus. Diabetologia (1978) 1.09
Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain. J Pharmacol Exp Ther (1968) 1.08
Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency. J Inherit Metab Dis (1995) 1.08
Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects. Clin Sci (Lond) (1980) 1.07
Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man. Acta Physiol Scand (1983) 1.06
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci U S A (1985) 1.06
Human forearm muscle metabolism during exercise. 3. Uptake, release and oxidation of beta-hydroxybutyrate and observations on the beta-hydroxybutyrate/acetoacetate ratio. Scand J Clin Lab Invest (1968) 1.06
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology (Berl) (1995) 1.05
Pyroglutamic aciduria. Studies in an infant with chronic metabolic acidosis. Acta Paediatr Scand (1974) 1.04
Muscle metabolism during exercise in hemiparetic patients. Clin Sci Mol Med (1977) 1.04
Utilization of blood-borne and intramuscular substrates during continuous and intermittent exercise in man. J Physiol (1977) 1.04
Two mutations within the coding sequence of the phenylalanine hydroxylase gene. Hum Genet (1990) 1.03
Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiatr Scand (1982) 1.03
Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics (2001) 1.01
Adrenergic transmission at vasoconstrictor nerve terminals partially depleted of noradrenaline. Acta Physiol Scand (1965) 1.01
Human forearm muscle metabolism during exercise. VI. Substrate utilization in prolonged fasting. Scand J Clin Lab Invest (1971) 1.00
Raclopride, a new selective ligand for the dopamine-D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry (1988) 1.00
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiatr Scand (1993) 0.99
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology (Berl) (1987) 0.99
Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. J Psychiatr Res (1986) 0.99
Turnover of individual free fatty acids in man. Fed Proc (1975) 0.99
Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression. Scand J Gastroenterol (1982) 0.99
Polymorphic DNA haplotypes at the phenylalanine hydroxylase locus and their relation to phenotype in Swedish phenylketonuria families. Hum Genet (1991) 0.98
Human forearm muscle metabolism during exercise. VII. FFA uptake and oxidation at different work intensities. Scand J Clin Lab Invest (1972) 0.97
Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. J Psychiatr Res (1985) 0.97
Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers. Psychopharmacology (Berl) (1989) 0.96
Pharmacokinetics of lithium in manic-depressive patients. Acta Psychiatr Scand (1973) 0.96
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse (1996) 0.96
Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12. Hum Mutat (1992) 0.96
Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics (1998) 0.96
Regional cerebral blood flow during experimental phobic fear. Psychophysiology (1993) 0.96
Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain Res (2001) 0.95
Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry (1988) 0.95
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology (Berl) (1989) 0.95
Turnover and splanchnic metabolism of free fatty acids in hyperthyroid patients. J Clin Invest (1981) 0.95
Metabolism of free fatty acids and ketone bodies during exercise in normal and diabetic man. Diabetes (1979) 0.95
Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res (1999) 0.95
Identification and determination of tele-methylhistamine in cerebrospinal fluid by gas chromatography-mass spectrometry. J Neurochem (1981) 0.94
Glutathione and gamma-glutamylcysteine in whole blood, plasma and erythrocytes. Clin Chim Acta (1978) 0.94
Symptoms and disability until 3 months after mild TBI. Brain Inj (2006) 0.94
11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors. Int J Rad Appl Instrum A (1988) 0.93
Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr (1993) 0.93
No D2 receptor increase in PET study of schizophrenia. Arch Gen Psychiatry (1987) 0.93
Severity of mutation in the phenylalanine hydroxylase gene influences phenylalanine metabolism in phenylketonuria and hyperphenylalaninaemia heterozygotes. J Inherit Metab Dis (1994) 0.93
Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology (Berl) (1996) 0.92
Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. Int J Appl Radiat Isot (1985) 0.92
Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry (1996) 0.92
Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin. Eur J Clin Invest (1985) 0.92
An extra C chromosome and various metabolic abnormalities in the bone marrow from a patient with refractory sideroblastic anaemia. Scand J Haematol (1971) 0.91
Glutamate and glutamine in cerebrospinal fluid and serum from healthy volunteers--analytical aspects. J Chromatogr (1988) 0.91
Characterization of human cleaved N-CAM and association with schizophrenia. Exp Neurol (2001) 0.91
Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden. J Affect Disord (2008) 0.91
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology (Berl) (1993) 0.91